Aceragen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Aceragen and buy or sell other stocks, ETFs, and their options commission-free!About ACGN
Aceragen, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of medications for rare and orphan diseases.
CEOJohn Clayton Taylor
CEOJohn Clayton Taylor
Employees—
Employees—
HeadquartersResearch Triangle Park, North Carolina
HeadquartersResearch Triangle Park, North Carolina
Founded1989
Founded1989
Employees—
Employees—
ACGN Key Statistics
Market cap3.20M
Market cap3.20M
Price-Earnings ratio-0.07
Price-Earnings ratio-0.07
Dividend yield—
Dividend yield—
Average volume44.14K
Average volume44.14K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$16.00
52 Week high$16.00
52 Week low$0.3601
52 Week low$0.3601
Stock Snapshot
The current Aceragen(ACGN) stock price is $0.38, with a market capitalization of 3.2M. The stock trades at a price-to-earnings (P/E) ratio of -0.07.
Aceragen(ACGN) stock opened on 2025-12-04 at —. The price climbed to — and dipped to —.
Aceragen(ACGN) shares are trading with a volume of 0, against a daily average of 44.14K.
During the past year, Aceragen(ACGN) stock moved between $0.36 at its lowest and $16.00 at its peak.
During the past year, Aceragen(ACGN) stock moved between $0.36 at its lowest and $16.00 at its peak.
People also own
Based on the portfolios of people who own ACGN. This list is generated using Robinhood data, and it’s not a recommendation.